DR.REDDY'S LABORATORIES LTD. - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in Financial Express on May 22, 2015 titled "Some drugs made by Lupin, DRL & Mylan lose EU approval"<BR><BR>Dr Reddys Laboratories Ltd replied stating "The matter referred to in the news item was ongoing for a small part of our marketed portfolio in Europe. The overall impact on the Company's financials of this development is expected to be quite insignificant. Hence, we did not see a stock exchange notification necessary."